Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.195 USD | -1.24% | +5.31% | -33.15% |
Mar. 14 | Transcript : Protalix BioTherapeutics, Inc., 2023 Earnings Call, Mar 14, 2024 | |
Mar. 14 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 74.06M | Sales 2025 * | 127M | Capitalization | 88.39M |
---|---|---|---|---|---|
Net income 2024 * | 17M | Net income 2025 * | 70M | EV / Sales 2024 * | 1.19 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.69 x |
P/E ratio 2024 * |
5.76
x | P/E ratio 2025 * |
1.49
x | Employees | 208 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.23% |
Latest transcript on Protalix BioTherapeutics, Inc.
1 day | +0.83% | ||
1 week | +5.22% | ||
Current month | -3.97% | ||
1 month | -4.72% | ||
3 months | -17.69% | ||
6 months | -20.39% | ||
Current year | -32.02% |
Managers | Title | Age | Since |
---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 57 | 19-06-29 |
Eyal Rubin
DFI | Director of Finance/CFO | 48 | 19-07-21 |
Yael Hayon
CTO | Chief Tech/Sci/R&D Officer | 41 | 20-07-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pol Boudes
BRD | Director/Board Member | 67 | 19-11-30 |
Gwen Melincoff
BRD | Director/Board Member | 72 | 19-11-30 |
Aharon Schwartz
BRD | Director/Board Member | 80 | 14-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.19 | -1.65% | 83 764 |
24-04-24 | 1.21 | +0.83% | 228,353 |
24-04-23 | 1.2 | +1.69% | 272,095 |
24-04-22 | 1.18 | +2.61% | 225,065 |
24-04-19 | 1.15 | +1.77% | 449,804 |
Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.02% | 88.39M | |
+4.09% | 43.84B | |
+47.81% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- PLX Stock